Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group (Q42628320)
Jump to navigation
Jump to search
scientific article published on December 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group |
scientific article published on December 1995 |
Statements
1 reference
Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group (English)
1 reference
Ingrand D
1 reference
Weber J
1 reference
Boucher CA
1 reference
Loveday C
1 reference
Robert C
1 reference
Hill A
1 reference
Cammack N
1 reference
1 December 1995
1 reference
1 reference
9
1 reference
12
1 reference
1323-1329
1 reference
Identifiers
1 reference